UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 20, 2013 (May 16, 2013)
Universal Biosensors, Inc.
(Exact Name of Issuer as Specified in Charter)
DELAWARE | 000-52607 | 98-0424072 | ||
(State or Other Jurisdiction of Incorporation or Organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
1 Corporate Avenue, Rowville, 3178, Victoria Australia |
Not Applicable | |
(Address of Principal Executive Offices) | (Zip Code) |
+61 3 9213 9000
(Registrants Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Item 5.07 Submission of Matters to a Vote of Security Holders.
Universal Biosensors, Inc (the Company) held its annual meeting of stockholders on May 16, 2013. At the meeting, the Companys stockholders (i) elected the Boards nominee (Marshall Heinberg) to serve as director of the Company until the 2016 annual meeting of stockholders, or until his successor is duly elected and qualified, (ii) approved the named senior executive compensation and (iii) authorized and approved the grant of 37,500 zero exercise price employee options to acquire shares of common stock (ZEPOs) and 917 restricted shares of common stock to the Companys Chief Executive Officer and director, Paul Wright (the CEO).
1. Election of Directors | For | Against | Abstained | |||||||||
Marshall Heinberg |
97,052,179 | 355,360 | 13,253 |
2. Approval of named senior executive compensation | For | Against | Abstained | |||||||||
96,358,771 | 827,910 | 234,111 |
3. Approval of grant of ZEPOs and restricted shares of common stock to the CEO | For | Against | Abstained | |||||||||
96,515,467 | 895,325 | 10,000 |
There were no broker non-votes for any of the matters listed above.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
UNIVERSAL BIOSENSORS, INC. | ||||||||
Date: May 16, 2013 | By: | /s/ Paul Wright | ||||||
Name: | Paul Wright | |||||||
Title: | Chief Executive Officer |